Advanced Biodesign
Records under this name other than the patents Advanced Biodesign holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to Advanced Biodesign
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,242,408 | Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis Lapsed on the fee record Ended Feb 8, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 8, 2026 | From the USPTO record |
| US 8,026,231 | Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof Term ended Term ended Aug 7, 2024 · From the USPTO record | Term ended | Term ended Aug 7, 2024 | From the USPTO record |
| US 7,078,402 | Aminothiolester Compounds, Pharmaceutical and Cosmetic Compositions Containing Same and Uses Thereof Term ended Term ended May 31, 2021 · High confidence | Term ended | Term ended May 31, 2021 | High confidence |